Cargando…
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
The incidence and mortality of esophageal cancer are high. Therefore, the authors aimed to investigate how the number of dissected lymph nodes (LNs) during esophagectomy for esophageal squamous cell carcinoma impacts overall survival (OS), particularly that of patients with positive LNs. MATERIALS A...
Autores principales: | Li, Kexun, Leng, Xuefeng, He, Wenwu, Du, Kunyi, Li, Changding, Liu, Kun, Wang, Chenghao, Liu, Guangyuan, Li, Zhiyu, Jiang, Longlin, Li, KunZhi, Zhou, Qiang, Li, Jialong, Luo, Xi, Nie, Xin, Lu, Simiao, Li, Haojun, Fang, Qiang, Xiao, Wenguang, Han, Yongtao, Peng, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389544/ https://www.ncbi.nlm.nih.gov/pubmed/37222685 http://dx.doi.org/10.1097/JS9.0000000000000436 |
Ejemplares similares
-
Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis
por: Li, Kexun, et al.
Publicado: (2023) -
The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis
por: He, Wenwu, et al.
Publicado: (2023) -
Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study
por: Zhou, Qiang, et al.
Publicado: (2023) -
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
por: He, Wenwu, et al.
Publicado: (2022) -
Optimal discharge planning for esophagectomy patients with enhanced recovery after surgery: Recommendations
por: Li, Kunzhi, et al.
Publicado: (2023)